Healthcare

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed clinical trial data...

Biotechnology firm Quanterix has taken a pivotal step toward transforming the diagnosis of Alzheimer's disease. The company has formally submitted...

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which concluded in late...

Formerly known as Allscripts Healthcare, Veradigm Inc. is navigating a critical period of corporate realignment with a dual-focused approach that...

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to concentrate on high-margin...

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business line and finalizes...

Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday, delivering revenue and...

Coherus BioSciences has secured a significant partnership for its clinical development efforts, aligning with Janssen Research & Development, a Johnson...

Akso Health Group has solidified its strategic shift into the healthcare industry with the launch of a major global program...

Since its acquisition by the private equity firm Sycamore Partners was finalized in the summer of 2025, Walgreens has embarked...